Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models

por Sugawara, Tatsuo, Baumgart, Simon J., Nevedomskaya, Ekaterina, Reichert, Kristin, Steuber, Holger, Lejeune, Pascale, Mumberg, Dominik, Haendler, Bernard
Publicado 2019